Skip to main content
Livermore
Livermore
ZHEN

First Trust Advisors LP

SEC CIK
0001125816
Latest filing
Aug 11, 2026

TAK holding history

Takeda Pharmaceutical Co Ltd in every 13F filed by First Trust Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TAK overviewAll 13F holders of TAKFull Q2 2026 holdings

Shares (Q2 2026)
2,114,912
Value
$33.9M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of TAK by First Trust Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,114,912$33.9M<0.1%+143,838+7.3%AddedHolders
Q1 20261,971,074$36.5M<0.1%−411,555−17.3%ReducedHolders
Q4 20252,382,629$37.1M<0.1%−134,810−5.4%ReducedHolders
Q3 20252,517,439$36.9M<0.1%−84,369−3.2%ReducedHolders
Q2 20252,601,808$40.2M<0.1%−154,147−5.6%ReducedHolders
Q1 20252,755,955$41.0M<0.1%−484,977−15.0%ReducedHolders
Q4 20243,240,932$42.9M<0.1%+62,718+2.0%AddedHolders
Q3 20243,178,214$45.2M<0.1%+3,178,214NewHolders
Q4 20230$00.0%−233,119−100.0%Sold outHolders
Q3 2023233,119$3.61M<0.1%+68,066+41.2%AddedHolders
Q2 2023165,053$2.59M<0.1%−243,710−59.6%ReducedHolders
Q1 2023408,763$6.74M<0.1%+179,939+78.6%AddedHolders
Q4 2022228,824$3.57M<0.1%−54,875−19.3%ReducedHolders
Q3 2022283,699$3.68M<0.1%−46,594−14.1%ReducedHolders
Q2 2022330,293$4.64M<0.1%−457,665−58.1%ReducedHolders
Q1 2022787,958$11.3M<0.1%−47,098−5.6%ReducedHolders
Q4 2021835,056$11.4M<0.1%−1,045,939−55.6%ReducedHolders
Q3 20211,880,995$30.8M<0.1%+336,324+21.8%AddedHolders
Q2 20211,544,671$26.0M<0.1%−315,586−17.0%ReducedHolders
Q1 20211,860,257$34.0M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.